News

Thermo Fisher Scientific announces the launch of a next-generation, compressor-free plate sealer, designed to alleviate the maintenance burden on operators, while offering unparalleled process customization capabilities, intuitive operation and significant work efficiencies. Biotechnology, pharmaceutical and academic research laboratories can...

CPhI’s ASEAN Pharma 2020 Report points points to Thailand and Indonesia having the largest near-term generics export potential, as regional executives come out in favour of an ASEAN-wide track and trace scheme. The report’s findings which have been...

Inceptua, a global pharmaceutical company and service partner and Portola – US developer and manufacturer of therapeutic agents focusing on thrombosis and other haematological conditions – have entered into an agreement whereby Inceptua will become Portola’s exclusive distribution partner...

Regeneron  announced an expanded agreement with the U.S. Department of Health and Human Services (HHS) to develop new treatments combating the novel coronavirus, 2019-nCoV, which was recently declared a global public health emergency by the World Health Organization. Regeneron has...

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that it has reached its patient enrollment target in the company's phase 2 clinical trial for glioblastoma. The trial has achieved its enrollment target ahead of...

The Sanofi phase 2b study evaluating its investigational BTK (Brutons tyrosine kinase) inhibitor (SAR442168), an oral, brain-penetrant, selective small molecule, achieved its primary endpoint. In the trial, SAR442168 significantly reduced disease activity associated with multiple sclerosis (MS) as measured by...

Teva Pharmaceutical Industries Ltd announced positive results from two Phase 2/3 trials evaluating AJOVY® (fremanezumab) in patients in Japan. AJOVY is under development in Japan by Otsuka Pharmaceutical Co., Ltd. (Otsuka) as part of a May 2017 exclusive license...